Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-25-020081
Filing Date
2025-10-29
Accepted
2025-10-29 16:30:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 18808
2 EX-1 ex1.htm EX-1 16421
  Complete submission text file 0001493152-25-020081.txt   37122
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Subject) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-93797 | Film No.: 251430435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000
Business Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000 852 31219699
ABG Management Ltd. (Filed by) CIK: 0001832106 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13D